Zenosense,
a healthcare technology company principally engaged in developing and marketing
devices to detect the MRSA “Super-Bug” and to detect signs of lung cancer in
exhaled breath, announced it has manufactured a pre-commercial prototype
device. The device is expected to be evaluated for the detection of lung cancer
in exhaled breath.
The work
involved in the prototyping process has been entrusted to the company’s
contracted development partner Zenon Biosystem (“Zenon”), a component of the
Sgenia group. In line with the protocol design for an anticipated lung cancer
detection trial, two pre-commercial devices are currently being manufactured
with the identical design, thereby ensuring the results are reproduced. The
devices are expected to be ready later this month.
The device
uses components that remove irrelevant Volatile Organic Compounds (“VOCs”) in
order to optimize the detection of target VOC biomarkers found in exhaled
breath and connected with the incidence of lung cancer. These components include
molecular sieves used in complementary layered and mixed sensor structures to
screen incoming VOCs, and nanometric sensing mesh to maximize the detective
area.
ZENO is
eagerly anticipates testing of the devices in the planned lung cancer detection
trial while work at Zenon is ongoing to establish the necessary outcomes to
carry out the trial. The company believes that a cost-effective lung cancer
detector analyzing exhaled breath proven meets or exceeds the accuracy of low
dose CT scanning will have wide appeal and subsequently satisfy demand.
Zenosense,
Inc., a detection device development company, outlays a mission to develop
effective medical devices targeting early detection of both deadly bacteria and
certain cancers in the exhaled breath of patients. Ultimately, the company
intends to sell these products to primary healthcare facilities and hospitals.
A device intended to detect the Methicillin-resistant Staphylococcus aureus
MRSA and a device intended to detect Lung Cancer are currently under development.
For more
information on the company, visit www.zenosense.net
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign up
for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The
Quality Stocks Daily Blog http://blog.qualitystocks.net
The
Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The
Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
No comments:
Post a Comment